Cyclo Therapeutics Enters Into Note Purchase Agreement and Amendment with Rafael Holdings

Cyclo Therapeutics, Inc. (NASDAQ: CYTH), a Nevada corporation, disclosed today that it has entered into a Fourth Amended and Restated Note Purchase Agreement with Rafael Holdings, Inc., a Delaware corporation. Under this agreement, Cyclo Therapeutics issued a convertible promissory note amounting to $3,000,000. The newly issued note, maturing on December 21, 2024, carries 5% annual […]

Leave a Reply

Your email address will not be published.

Previous post Acme United (NYSE:ACU) versus DAC Technologies Group International (OTCMKTS:DAAT) Head-To-Head Analysis
Next post **Lakeland Financial (NASDAQ:LKFN) Reports Submission of Form 8-K**